Cafepharma Today

June 20 2025 - Gene therapy faces fresh uncertainty as two more top FDA officials depart
Gene therapy faces fresh uncertainty as two more top FDA officials depart
Eli Lilly (LLY) sees strong demand for Mounjaro in India
A longer ‘winter’: Public funding slowdown heightens pressure on biotech startups
Is DTC pharma advertising coming to an end?
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA issues long-awaited plan for electronic labeling
Medical Marketing and Media
Thursday, December 18, 2014 - 10:02am
tags:
FDA, electronic labeling
GlaxoSmithKline shingles vaccine hits goal in major study
Yahoo/Reuters
Thursday, December 18, 2014 - 10:01am
tags:
GSK, vaccines, shingles, HZ/su
AstraZeneca first-in-class ovarian cancer drug wins EU approval
Yahoo/Reuters
Thursday, December 18, 2014 - 9:01am
tags:
AstraZeneca, ovarian cancer, Europe, Lynparza, olaparib
Takeda Names Sanofi’s Andrew Plump as Head of Research
Bloomberg
Thursday, December 18, 2014 - 8:59am
tags:
Takeda, Sanofi, R&D
More CEO watchers put Gilead's Martin on their 'best of 2014' lists
Fierce Pharma Marketing
Wednesday, December 17, 2014 - 10:10pm
tags:
Gilead Sciences, John Martin
Tetraphase spikes on a Phase III success for lead antibiotic
Fierce Biotech
Wednesday, December 17, 2014 - 9:41pm
tags:
antibiotics, Tetraphase Pharmaceuticals, Eravacycline
J&J rents Halozyme's R&D technology for up to $581M
Fierce Biotech
Wednesday, December 17, 2014 - 9:32pm
tags:
JNJ, Halozyme, R&D, Enhanze, Janssen Biotech
Biopharma's R&D budgets stay about flat amid global cuts
Fierce Biotech
Wednesday, December 17, 2014 - 4:23pm
tags:
R&D, CROs, biotech
Amgen Leukemia Therapy Costs $178,000, Among Priciest Drugs
Bloomberg
Wednesday, December 17, 2014 - 4:20pm
tags:
drug pricing, Amgen, Blincyto, acute lymphoblastic leukemia
Shire Said to Weigh Offer for NPS as It Revisits Deals
Bloomberg
Wednesday, December 17, 2014 - 12:39pm
tags:
Shire, NPS Pharmaceuticals, M&A
Amgen vet reveals stealth startup Flexus backed by $38M from Kleiner Perkins, Celgene
Fierce Biotech
Wednesday, December 17, 2014 - 10:06am
tags:
Flexus, Celgene, Amgen, cancer immunotherapy
Pozen gets another FDA cold shoulder for its cardio drugs
Fierce Biotech
Wednesday, December 17, 2014 - 10:05am
tags:
Pozen, FDA
2015 Biotech Drug/Stock Outlook: Here's What You Need to Know
TheStreet.com
Wednesday, December 17, 2014 - 10:02am
tags:
Biogen Idec, Bluebird Bio, Arrowhead Research, Vertex Pharmaceuticals, Cempra, CTI BioPharma, Gilead Sciences, Merck, Bristol-Myers Squibb, Sarepta Therapeutics, Neurocrine Biosciences
Novartis sues Cipla over respiratory drug Onbrez
Yahoo/Reuters
Wednesday, December 17, 2014 - 9:57am
tags:
Novartis, Cipla, Onbrez
Medivation Poised To Expand As Xtandi Shows Efficacy In Advanced Triple Negative Breast Cancer
Seeking Alpha
Wednesday, December 17, 2014 - 8:53am
tags:
Medivation, Xtandi, triple negative breast cancer, breast cancer
FDA Okays Novartis AG’s (NVS) Signifor LAR To Treat Acromegaly
Bidness Etc.
Wednesday, December 17, 2014 - 8:32am
tags:
Novartis, FDA, Signifor LAR, acromegaly
Pfizer, Inc. Invests in Growth... Literally
Motley Fool
Wednesday, December 17, 2014 - 8:26am
tags:
Pfizer, OPKO Health, human growth hormone
Philips Buys Volcano for $1 Billion to Boost Medical Imaging
Bloomberg
Wednesday, December 17, 2014 - 8:15am
tags:
Philips, Volcano Corporation, M&A, devices, Medical Imaging
3 Companies Growing Faster Than MannKind Corporation
Motley Fool
Wednesday, December 17, 2014 - 8:13am
tags:
MannKind, Alexion, Akorn, Acorda Therapeutics
UCB Cancels Sale of Generic-Drug Unit to Buyout Firms
Bloomberg
Wednesday, December 17, 2014 - 8:04am
tags:
UCB Pharmaceuticals, M&A, generics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Stir Bars Can't Be Ignored
In the Pipeline
AI Effects on Drug Patents
In the Pipeline
Mirror Morphine
In the Pipeline
Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.